Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study evaluated the safety and effectiveness of ONO-1110 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including FukuokaThis study evaluated the safety and effectiveness of ONO-1110 for people with anxiety.
This study has finished and is no longer accepting participants.
Multiple locations, including FukuokaIbogaine to Determine Maximum Tolerated Dose (MTD) or Treat-to-Target Dose (TTD) for the Evaluation of Efficacy and Safety
This study has finished and is no longer accepting participants.
Multiple locations, including ManchesterA Multicentric, Randomized, Double-Blind, Placebo- and Positive-Controlled 4-way Crossover Study to Evaluate the Effects of Single and Repeated Administration of Oral Seltorexant as an add-on Medication to an Antidepressant on On-Road Driving Performance in Participants With Major Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including AlkenOpen-Label, Parallel, Randomized, Multiple-Dose Pharmacokinetic Study of Paliperidone After Intramuscular Injection of Paliperidone Palmitate in the Deltoid or Gluteal Muscle in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedDisposition of Paliperidone Enantiomers After Treatment With Different Formulations of the Racemate and the Separate Enantiomers and the Determination of the Absolute Bioavailability of IR and ER OROS Paliperidone
This study has finished and is no longer accepting participants.
Location not clearly listedA Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Double-blind, Randomized, Active-controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation
This study has finished and is no longer accepting participants.
Multiple locations, including RogersA Long-Term, Open-Label Study of Flexibly Dosed Paliperidone Palmitate Long-Acting Intramuscular Injection in Japanese Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including AsahiResearchers studied Paliperidone Palmitate to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Baoding
Prospective Study to Assess, Outcomes and Healthcare Resource Use of Current Standard of Care for Patients With Moderate or sEvere MDD Requiring Urgent Symptom Control in a Psychiatric Emergency: POWER
This study was withdrawn before enrollment.
Location not clearly listedA Phase II Tolerability and Efficacy Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD), Part I
This study has finished and is no longer accepting participants.
In San FranciscoWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.